• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA CANADA CORP CROWN PRT PERICARDIAL HEART VALVE; TISSUE HEART VALVES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA CANADA CORP CROWN PRT PERICARDIAL HEART VALVE; TISSUE HEART VALVES Back to Search Results
Model Number CNA23
Device Problems Gradient Increase (1270); Incomplete Coaptation (2507); Device Operates Differently Than Expected (2913)
Patient Problems Aortic Regurgitation (1716); Aortic Valve Stenosis (1717); No Information (3190)
Event Date 08/22/2017
Event Type  malfunction  
Event Description
On (b)(6) 2017 a crown prt aortic heart valve size 23mm was implanted.After the procedure (on the second day) an echo displayed abnormal findings where the physician noted that the tip of one of the leaflets was not functioning as expected.On (b)(6) 2017 re-operation was performed and the crown valve was explanted.The physician noted that the valve appeared to be functioning as bi-cuspid as one leaflet was not opening and appeared damaged.
 
Event Description
Prior to device explant the tee showed high gradient and stenosis of the valve.An edwards magna size 23 was implanted after the crown device was explanted.The echo showed the bioprosthesis in the right position and function with max.Gradient 24mmhg, no leak.
 
Manufacturer Narrative
The returned valve prosthesis was received in general good conditions.Visual inspection showed all three leaflets appeared to be equally pliable but stiffened, which is consistent with valves that have been returned and decontaminated.Visibly, all three leaflets appear to be sewn into place at all three posts and at the base of the covered stent.The sewing ring is noticeably deformed.The function test video was reviewed to qualitatively evaluate the valve in 4 phases: closed, opening, open and closing.Video showed synchronous opening and closing with smooth continuous motion and no leaflet fluttering.Meets all function test criteria observable on video for as size 23 crown prt.The external review of the echocardiogram report: on (b)(6) 2017 ¿ tee - there is a bioprosthetic valve in aortic position.The valve is opening like a bicuspid valve in that the single piece of pericardium seems to be detached from one of the prosthetic struts.There is at least moderate aortic regurgitation that seems to be central (not paravalvular).The manufacturer is continuing analysis of the returned device to determine the root cause of this event, as of investigation results received to date the probable cause is patient anatomy factors.This will be clarified through further emdr once known.
 
Manufacturer Narrative
Review of the data filed in the device history record confirmed that the returned valve satisfied all material, dimensional, and performance standards required for crown prt valve cna23 - sn (b)(4) at the time of manufacture and release.The visual inspection performed on the returned prosthesis confirmed the absence of pre-existing defects.A deformed geometry of the valve was detected.The hydrodynamic testing conducted on the returned prosthesis confirmed that the device fully respects the requirements of iso 5840 except a delay on leaflet 3 during the valve opening and closing phases, reasonably correspondant to the reported event.Nevertheless no regurgitation or coaptation defects were observed also taking in consideration the not optimal valve conditions.The anatomical morphology or the suture technique can be the root cause of the induced deformation and anomalous leaflets behavior.Based on the performed analysis the reported event cannot be explained by any factor intrinsic in the involved device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CROWN PRT PERICARDIAL HEART VALVE
Type of Device
TISSUE HEART VALVES
Manufacturer (Section D)
LIVANOVA CANADA CORP
5005 north fraser way
burnaby, bc V5J5M 1
CA  V5J5M1
Manufacturer (Section G)
LIVANOVA CANADA CORP
5005 north fraser way
burnaby, bc
Manufacturer Contact
francesca crovato
5005 north fraser way
burnaby, bc 
MDR Report Key6877356
MDR Text Key86706354
Report Number3004478276-2017-00161
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00896208000528
UDI-Public(01)00896208000528(240)CNA23(17)220430
Combination Product (y/n)N
Reporter Country CodeLO
PMA/PMN Number
P060038
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date 12/21/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/19/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Physician
Device Expiration Date04/30/2022
Device Model NumberCNA23
Device Catalogue NumberCNA23
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/07/2017
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/21/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/25/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-